T2SARS-COV-2

Serial Number 97238833
Registration 6957307
700

Registration Progress

Application Filed
Jan 26, 2022
Under Examination
Approved for Publication
Nov 1, 2022
Published for Opposition
Nov 1, 2022
Registered
Jan 17, 2023

Trademark Image

T2SARS-COV-2

Basic Information

Serial Number
97238833
Registration Number
6957307
Filing Date
January 26, 2022
Registration Date
January 17, 2023
Published for Opposition
November 1, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 17, 2023
Registration
Registered
Classes
001 005

Rights Holder

T2 Biosystems, Inc.

03
Address
101 Hartwell Avenue
Lexington, MA 02421

Ownership History

T2 Biosystems, Inc.

Original Applicant
03
Lexington, MA

T2 Biosystems, Inc.

Owner at Publication
03
Lexington, MA

T2 Biosystems, Inc.

Original Registrant
03
Lexington, MA

Legal Representation

Attorney
Karen L. Elbing

USPTO Deadlines

Next Deadline
1083 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230117)
Due Date
January 17, 2029
Grace Period Ends
July 17, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Jan 17, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 17, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 1, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 12, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 29, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 1, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 29, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Assays for identification and analysis of SARS-CoV-2 virus infections for use in biological and chemical research
First Use Anywhere: Jun 30, 2020
First Use in Commerce: Jun 30, 2020
Class 005
Diagnostic reagents for identification and analysis of SARS-CoV-2 virus infections for medical use, medical diagnostic assays for testing biological fluids for SARS-CoV-2 virus infections; medical diagnostic assays for testing of body fluids, namely, assays for use in medical and clinical diagnostics of SARS-CoV-2 virus infections
First Use Anywhere: Jun 30, 2020
First Use in Commerce: Jun 30, 2020

Classification

International Classes
001 005